Action Amgen - AMGN

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me

Denosumab Trial Met Primary and All Secondary Endpoints by Significantly Delaying Time to First Skeletal Related Event and Significantly Reducing First-and-Subsequent Skeletal Related Events...

Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share

Fourth Quarter 2009 Revenue Increased 2 Percent to $3.8 Billion; Full Year 2009 Revenue Decreased 2 Percent to $14.6 Billion Fourth Quarter 2009 GAAP Earnings Per Share Increased 6 Percent to...

Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium

THOUSAND OAKS, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in...

Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results

THOUSAND OAKS, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that it plans to report its fourth quarter and full year financial results on Monday, Jan. 25, 2010...

Amgen Donates $2 Million, Establishes Earthquake Relief Program

Company, Staff Contributions To Help Haitian Victims THOUSAND OAKS, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that the company will donate $2 million to Haiti...

Amgen to Present at the 28th Annual JP Morgan Healthcare Conference

THOUSAND OAKS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) will present at the 28th Annual JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time on Tuesday, Jan. 12...

Amgen Resolves EPO Patent Dispute With Roche

Roche Admits Infringement And Validity Of Amgen's EPO Patents; Court Enters Permanent Injunction; Amgen Allows Roche's MIRCERA Onto U.S. Market In Mid-2014 THOUSAND OAKS, Calif., Dec. 22...

Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines

THOUSAND OAKS, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) announced today that Roger M. Perlmutter, M.D., Ph. D., Amgen's executive vice president of Research & Development...

Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

THOUSAND OAKS, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that its board of directors has authorized repurchases of up to an additional $5 billion in Amgen...

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists

Applications for 2010 Amgen Scholars U.S. and Europe Programs Now Available THOUSAND OAKS, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Each year, hundreds of undergraduate students from across the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AMGN - Frequently Asked Questions (FAQ)

What is the current Amgen share price?

The current share price of Amgen is 0,00 €

What is the 1 year trading range for Amgen share price?

Amgen has traded in the range of 0,00 € to 0,00 € during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
WHQF25High Quality Food Spa	0,033 € (65,00%)	55k
AATAA Tech SpA	0,795 € (30,33%)	255k
WERFOLaboratorio Farmaceutico Erfo SPA	0,0414 € (29,78%)	730
WAMB26Ambromobiliare SpA	0,05 € (25,00%)	10k
1VBKVerbio SE	12,15 € (24,04%)	315
WTFINTrevi Finanziaria Industriale Spa	0,7001 € (-29,99%)	10,75k
EPHEPH SpA	0,103 € (-23,70%)	26,55k
BIROEstrima Spa	0,354 € (-17,29%)	166,8k
MNLMonnalisa SPA	1,64 € (-12,77%)	219,87k
1NKLANikola Corp	1,17 € (-11,48%)	100
TITTelecom Italia SpA	0,2488 € (0,89%)	87,51M
SPMSaipem Spa	2,647 € (5,50%)	43,11M
ISPIntesa Sanpaolo Spa	3,832 € (-0,80%)	40,37M
BPEBper Banca SPA	5,924 € (-3,42%)	20,82M
TITRTelecom Italia	0,291 € (0,52%)	13,64M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amgen Inc (AMGN)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AMGN Dernières nouvelles

Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me

Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share

Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium

Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results

Amgen Donates $2 Million, Establishes Earthquake Relief Program

Amgen to Present at the 28th Annual JP Morgan Healthcare Conference

Amgen Resolves EPO Patent Dispute With Roche

Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines

Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists

AMGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amgen Inc (AMGN) Cours

Amgen Inc (AMGN)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AMGN Dernières nouvelles

AMGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE